Our Tax team has a long tradition of effectively resolving complex tax and business challenges for corporations and individuals before they incur significant cost. As rapid developments in the world economy transform tax laws, new and complicated legal challenges emerge. Working with each of our clients, we develop customized strategies and implement innovative solutions to deal effectively with these challenges. We manage complex and precedent-setting tax problems and opportunities critical to US and international transactions via diversified legal transactional resources, as well as the planning, litigation and regulatory services necessary to address our clients' short- and long-term tax objectives.

Efficient & Effective: Recognized, results-driven resolution of complex and precedent-setting tax problems and opportunities critical to US and international transactions.

Extensively Experienced: All major areas of corporate, partnership, individual, employment, tax-exempt organization, financial products, complex investment structures, real estate, REITs, trusts and estates, and transfer tax law.

Easy to Work With: Closely coordinate and work with, and manage clients' teams of in-house, legal and other professionals/independent advisors in accounting, financial planning, economics, and other disciplines.

2020 CARES Act: FAQs for Nonprofits
50+: Lawyers on our recognized and respected Tax team.
#1: Our focus on developing and implementing custom strategies that resolve a client's complex public or personal tax, business and wealth transfer challenges.

Experience Highlights

  • Carestream Health Inc., an Onex portfolio company, in the sale of its healthcare information systems (HCIS) business to Royal Philips, a global leader in health technology.
  • ASP Unifrax Holdings Inc., an American Securities portfolio company, and a global supplier of high-performance specialty fibers, in its sale to Clearlake Capital Group LP.
  • Pfizer, Inc. in its creation of Cerevel Therapeutics LLC, a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system (CNS). Funds affiliated with Bain Capital Private Equity and Bain Capital Life Sciences have committed $350 million with the ability to provide additional capital should it be needed in the future.
  • Sovereign wealth fund in connection with a $1 billion equity investment in a major institutional investment advisor.
  • Australian superannuation funds in various private equity, venture capital and hedge fund investments.
  • First American International Corporation in merger with subsidiary of RBB Bancorp Inc. The merger was structured as a tax-free reorganization for US federal income tax purposes.
  • Union Acquisition Corp. (UAC) (which subsequently changed its name to Bioceres Crop Solutions Corp. and is listed on the New York Stock Exchange) in connection with its entry into a definitive agreement to consummate a business combination with leading Latin American agricultural biotech company, Bioceres Inc., a subsidiary of Bioceres SA.
  • Ad hoc group of term lenders—comprised of Eaton Vance, Silver Point Capital, Symphony Asset Management, Franklin Mutual Advisors, LLC, Beach Point Capital, Highland Capital, and Voya Investment Management—in the successful restructuring of Cumulus Media Inc.
  • Ad hoc group of term lenders to iHeart Media, Inc. (iHeart)—comprised of more than 50 funds managed by Eaton Vance, OppenheimerFunds and Symphony Asset Management—with regard to the successful restructuring of iHeart's approximately $16 billion of debt.
  • Healthcare REIT, as special REIT tax counsel, in connection with acquisition of a $2.4 billion portfolio of healthcare facilities in 11 states.
Subscribe Link

Email Disclaimer